Recent studies have unveiled copy number variants (CNVs) as an important source of genetic variation. Many of these CNVs contain coding sequences, which have been shown to be dosage sensitive. Evidence is accumulating that certain CNVs have impact on susceptibility to human diseases such as HIV infection and autoimmune diseases, as well as on adaptability to environmental conditions or nutrition. The possible role and impact of CNVs on cancer development and progression is only now emerging. In this review we look into the role of CNVs and their associated genomic structural features in relation to the formation of chromosome alterations in cancer cells and evolutionary genomic plasticity, as well as the de novo occurrence of known or putative CNVs as somatic events during oncogenesis. The role of germline CNVs in cancer predisposition is still largely unexplored. A number of observations seem to warrant the importance of further studies to elucidate the impact of these variants in the early steps of carcinogenesis.

1.
Albertson DG: Gene amplification in cancer. Trends Genet 22:447–455 (2006).
2.
Barbouti A, Stankiewicz P, Nusbaum C, Cuomo C, Cook A, et al: The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats. Am J Hum Genet 74:1–10 (2004).
3.
Basecke J, Whelan JT, Griesinger F, Bertrand FE: The MLL partial tandem duplication in acute myeloid leukaemia. Br J Haematol 135:438–449 (2006).
4.
Bauters M, Van Esch H, Friez MJ, Boespflug-Tanguy O, Zenker M, et al: Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res 18:847–858 (2008).
5.
Bignell GR, Santarius T, Pole JC, Butler AP, Perry J, et al: Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 17:1296–1303 (2007).
6.
Braude I, Vukovic B, Prasad M, Marrano P, Turley S, et al: Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. BMC Genomics 7:138 (2006).
7.
Buysse K, Crepel A, Menten B, Pattyn F, Antonacci F, et al: Mapping of 5q35 chromosomal rearrangements within a genomically unstable region. J Med Genet 45:672–678 (2008).
8.
Campbell PJ, Stephens PJ, Pleasance ED, O’Meara S, Li H, et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722–729 (2008).
9.
Camps J, Grade M, Nguyen QT, Hormann P, Becker S, et al: Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 68:1284–1295 (2008).
10.
Cardone MF, Jiang Z, D‘Addabbo P, Archidiacono N, Rocchi M, et al: Hominoid chromosomal rearrangements on 17q map to complex regions of segmental duplication. Genome Biol 9:R28 (2008).
11.
Chanalaris A, Brazma D, Rai L, Chanalaris A, Howard J, et al: Genome profile of Ph-positive ALL in adult patients. 13th Congress of the European Hematology Association, Copenhagen, Denmark (2008).
12.
Chin L, Gray JW: Translating insights from the cancer genome into clinical practice. Nature 452:553–563 (2008).
13.
Collins I, Workman P: New approaches to molecular cancer therapeutics. Nat Chem Biol 2:689–700 (2006).
14.
Darai-Ramqvist E, Sandlund A, Muller S, Klein G, Imreh S, Kost-Alimova M: Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions. Genome Res 18:370–379 (2008).
15.
De Raedt T, Stephens M, Heyns I, Brems H, Thijs D, et al: Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletion. Nat Genet 38:1419–1423 (2006).
16.
Diskin SJ: A genome-wide association study (GWAS) of copy number variants (CNVs) identifies neuroblastoma predisposition loci. Advances in Neuroblastoma Research meeting, Tokyo, Japan (2008).
17.
Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet 7:85–97 (2006).
18.
Gibcus JH, Kok K, Menkema L, Hermsen MA, Mastik M, et al: High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications. Hum Genet 121:187–201 (2007).
19.
Graveley BR: Molecular biology: power sequencing. Nature 453:1197–1198 (2008).
20.
Heim S, Mitelman F: Molecular screening for new fusion genes in cancer. Nat Genet 40:685–686 (2008).
21.
Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al: Detection of large-scale variation in the human genome. Nat Genet 36:949–951 (2004).
22.
Imreh S, Kholodnyuk I, Allikmetts R, Stanbridge EJ, Zabarovsky ER, Klein G: Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Genes Chromosomes Cancer 11:237–245 (1994).
23.
Kallioniemi A: CGH microarrays and cancer. Curr Opin Biotechnol 19:36–40 (2008).
24.
Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, et al: Mapping and sequencing of structural variation from eight human genomes. Nature 453:56–64 (2008).
25.
Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, et al: Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 39:593–595 (2007).
26.
Laureys G, Versteeg R, Speleman F, van der Drift P, Francke U, et al: Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13; q11.2-q12) and neuroblastoma. Eur J Cancer 31A:523–526 (1995).
27.
Lindsay SJ, Khajavi M, Lupski JR, Hurles ME: A chromosomal rearrangement hotspot can be identified from population genetic variation and is coincident with a hotspot for allelic recombination. Am J Hum Genet 79:890–902 (2006).
28.
Mardis ER: The impact of next-generation sequencing technology on genetics. Trends Genet 24:133–141 (2008).
29.
Mendrzyk F, Korshunov A, Toedt G, Schwarz F, Korn B, et al: Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats. Genes Chromosomes Cancer 45:401–410 (2006).
30.
Michels E, De Preter K, Van Roy N, Speleman F: Detection of DNA copy number alterations in cancer by array comparative genomic hybridization. Genet Med 9:574–584 (2007).
31.
Mitelman F, Johansson B, Mertens F: The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233–245 (2007).
32.
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, et al: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758–764 (2007).
33.
Pinkel D, Albertson DG: Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 Suppl:S11–S17 (2005).
34.
Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444:444–454 (2006).
35.
Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, et al: A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation. Proc Natl Acad Sci USA 99:9882–9887 (2002).
36.
Samonte RV, Eichler EE: Segmental duplications and the evolution of the primate genome. Nat Rev Genet 3:65–72 (2002).
37.
Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68–73 (1997).
38.
Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al: Large-scale copy number polymorphism in the human genome. Science 305:525–528 (2004).
39.
Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, et al: Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44:305–319 (2005).
40.
Shaw CJ, Lupski JR: Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 13 Spec No 1:R57–R64 (2004).
41.
Speicher MR, Carter NP: The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6:782–792 (2005).
42.
Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848–853 (2007).
43.
Vandepoele K, Van Roy N, Staes K, Speleman F, van Roy F: A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution. Mol Biol Evol 22:2265–2274 (2005).
44.
Vandepoele K, Andries V, Van Roy N, Staes K, Vandesompele J, et al: A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS ONE 3:e2207 (2008).
45.
Weinberg RA: The Biology of Cancer (Garland Science, Taylor & Francis Group, LLC, Abingdon 2008).
46.
Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103:9136–9141 (2006).
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.